Abstract
In advanced Parkinson’s disease, several therapeutical option including not only lesional surgery (VIM, GPi) and deep brain stimulation (STN, GPi, VIM) but also continuous subcutaneous apomorphine infusion therapy can be proposed to the patient. The choice depends on the hope of the patient, patient’s general health condition and the experience and choice of the neurosurgical and neurologist team. Here we report our experience based on 400 STN-DBS cases and we discuss, on the basis of our experience and on the literature, the advantage and disadvantage of DBS strategy as compared with non-surgical option such as continuous subcutaneous apomorphine infusion therapy.
Similar content being viewed by others
References
Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448–458
Alegret M, Valldeoriola F, Marti M, Pilleri M, Junque C, Rumia J et al (2004) Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson’s disease. Mov Disord 19:1463–1469
Alesch F (2005) Sudden failure of dual channel pulse generators. Mov Disord 20:64–66 discussion 66
Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L et al (2007) Duodenal levodopa infusion for advanced Parkinson’s disease: 12-month treatment outcome. Mov Disord 22:1145–1149
Antonini A, Mancini F, Canesi M, Zangaglia R, Isaias IU, Manfredi L et al (2008) Duodenal levodopa infusion improves quality of life in advanced Parkinson’s disease. Neurodegener Dis 5:244–246
Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P et al (1999) Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46:217–223
Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J (1993) Chronic VIM thalamic stimulation in Parkinson’s disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 58:39–44
Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol 8:67–81
Binder DK, Rau GM, Starr PA (2005) Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 56:722–732 discussion 722–732
Burchiel KJ (1995) Thalamotomy for movement disorders. Neurosurg Clin N Am 6:55–71
Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J (2004) Suicide after successful deep brain stimulation for movement disorders. Neurology 63:2170–2172
Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G et al (2002) Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 59:932–934
Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y et al (2005) Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? J Neurol Neurosurg Psychiatry 76:775–779
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908
Diamond A, Jankovic J (2005) The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry 76:1188–1193
Dujardin K, Defebvre L, Krystkowiak P, Blond S, Destee A (2001) Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson’s disease. J Neurol 248:603–611
Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, van Laar T et al (2009) Long-term superiority of subthalamic nucleus stimulation over pallidotomy in Parkinson disease. Neurology 73:151–153
Ferraye MU, Debu B, Fraix V, Goetz L, Ardouin C, Yelnik J et al (2010) Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain 133:205–214
Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A et al (2001) Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease. 2000. Neurology 57:S60–S62
Fraix V, Houeto JL, Lagrange C, Le Pen C, Krystkowiak P, Guehl D et al (2006) Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:443–449
Fraix V, Chabardes S, Krainik A, Seigneuret E, Grand S, Le Bas JF, Krack P, Benabid AL, Pollak P (2010) Effects of magnetic resonance imaging in patients with implanted deep brain stimulation systems. J Neurosurg 113(6):1242–1245
Frank MJ, Samanta J, Moustafa AA, Sherman SJ (2007) Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism. Science 318:1309–1312
Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H et al (2004) Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:834–839
Goodman RR, Kim B, McClelland S 3rd, Senatus PB, Winfield LM, Pullman SL et al (2006) Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:12–17
Hamani C, Richter E, Schwalb JM, Lozano AM (2005) Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery 56:1313–1321 discussion 1321–1324
Hariz MI (2002) Complications of deep brain stimulation surgery. Mov Disord 17(Suppl 3):S162–S166
Hariz MI, Bergenheim AT (2001) A 10-year follow-up review of patients who underwent Leksell’s posteroventral pallidotomy for Parkinson disease. J Neurosurg 94:552–558
Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C (2008) Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov Disord 23:416–421
Herzog J, Volkmann J, Krack P, Kopper F, Potter M, Lorenz D et al (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18:1332–1337
Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T et al (2009) Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24:1468–1474
Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST et al (2002) Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 72:701–707
Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE et al (1998) Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol 44:622–628
Joint C, Nandi D, Parkin S, Gregory R, Aziz T (2002) Hardware-related problems of deep brain stimulation. Mov Disord 17(Suppl 3):S175–S180
Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R et al (2006) Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21(Suppl 14):S290–S304
Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A et al (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121(Pt 3):451–457
Krack P, Kumar R, Ardouin C, Dowsey PL, McVicker JM, Benabid AL et al (2001) Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 16:867–875
Krack P, Fraix V, Mendes A, Benabid AL, Pollak P (2002) Postoperative management of subthalamic nucleus stimulation for Parkinson’s disease. Mov Disord 17(Suppl 3):S188–S197
Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925–1934
Lagrange E, Krack P, Moro E, Ardouin C, Van Blercom N, Chabardes S et al (2002) Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 59:1976–1978
Lang AE, Lozano AM (1998) Parkinson’s disease. Second of two parts. N Engl J Med 339:1130–1143
Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E et al (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91–95
Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D et al (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339:1105–1111
Lozano AM, Lang AE (2001) Pallidotomy for Parkinson’s disease. Adv Neurol 86:413–420
Lozano AM, Snyder BJ (2008) Deep brain stimulation for parkinsonian gait disorders. J Neurol 255(Suppl 4):30–31
Lyons KE, Wilkinson SB, Overman J, Pahwa R (2004) Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 63:612–616
Macia F, Perlemoine C, Coman I, Guehl D, Burbaud P, Cuny E et al (2004) Parkinson’s disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 19:206–212
Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D et al (2008) Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 359:2121–2134
Meissner W, Trottenberg T, Klaffke S, Paul G, Kuhn AA, Arnold G et al (2001) Apomorphine therapy versus deep rain stimulation. Clinical and economic aspects in patients with advanced Parkinson disease. Nervenarzt 72:924–927
Moreau C, Defebvre L, Destee A, Bleuse S, Clement F, Blatt JL et al (2008) STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 71:80–84
Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE (2010) Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord 25(5):578–586
Ohye C, Shibazaki T, Sato S (2005) Gamma knife thalamotomy for movement disorders: evaluation of the thalamic lesion and clinical results. J Neurosurg 102(Suppl):234–240
Ostergaard K, Sunde N, Dupont E (2002) Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations. Mov Disord 17:693–700
Pahwa R, Wilkinson SB, Overman J, Lyons KE (2003) Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J Neurosurg 99:71–77
Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI (2006) Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 5:578–588
Piallat B, Chabardes S, Torres N, Fraix V, Goetz L, Seigneuret E et al (2009) Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience 158:1201–1205
Pietz K, Hagell P, Odin P (1998) Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up. J Neurol Neurosurg Psychiatry 65:709–716
Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H et al (2000) Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease. Neurology 55:411–418
Poewe W, Wenning GK (2000) Apomorphine: an underutilized therapy for Parkinson’s disease. Mov Disord 15:789–794
Pollak P (2007) Deep brain stimulation for movement disorders. In: Jankovic J (ed) Parkinson’s disease and movements disorders. Lippincott Williams & Wilkins, Philadelphia, pp 653–691
Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S et al (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128:2240–2249
Samanta J, Hauser RA (2007) Duodenal levodopa infusion for the treatment of Parkinson’s disease. Expert Opin Pharmacother 8:657–664
Schoenen J, Di Clemente L, Vandenheede M, Fumal A, De Pasqua V, Mouchamps M et al (2005) Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain 128:940–947
Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B (2007) Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir (Wien) 149:867–875 discussion 876
Sillay KA, Larson PS, Starr PA (2008) Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 62:360–366 discussion 366–367
Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D et al (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130:1596–1607
Stibe C, Lees A, Stern G (1987) Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations. Lancet 1:871
Stibe CM, Lees AJ, Kempster PA, Stern GM (1988) Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet 1:403–406
Strowd RE, Cartwright MS, Passmore LV, Ellis TL, Tatter SB, Siddiqui MS (2010) Weight change following deep brain stimulation for movement disorders. J Neurol 257(8):1293–1297
Tasker RR (1990) Thalamotomy. Neurosurg Clin N Am 1:841–864
Thobois S, Ardouin C, Lhommee E, Klinger H, Lagrange C, Xie J et al (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 133:1111–1127
Tseng HM, Su PC, Liu HM, Liou HH, Yen RF (2007) Bilateral subthalamotomy for advanced Parkinson disease. Surg Neurol 68(Suppl 1):S43–S50 discussion S50–S51
Varma TR, Fox SH, Eldridge PR, Littlechild P, Byrne P, Forster A et al (2003) Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson’s disease patients previously reliant on apomorphine. J Neurol Neurosurg Psychiatry 74:170–174
Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J (2002) Subthalamic DBS replaces levodopa in Parkinson’s disease: two-year follow-up. Neurology 58:396–401
Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, Spincemaille G et al (2005) Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord 11:157–165
Voon V, Moro E, Saint-Cyr JA, Lozano AM, Lang AE (2005) Psychiatric symptoms following surgery for Parkinson’s disease with an emphasis on subthalamic stimulation. Adv Neurol 96:130–147
Voon V, Potenza MN, Thomsen T (2007) Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Curr Opin Neurol 20:484–492
Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N et al (2009) Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140–1149
Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J et al (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59:408–413
Witjas T, Kaphan E, Regis J, Jouve E, Cherif AA, Peragut JC et al (2007) Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson’s disease. Mov Disord 22:1729–1734
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carron, R., Fraix, V., Maineri, C. et al. High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review. J Neural Transm 118, 915–924 (2011). https://doi.org/10.1007/s00702-010-0556-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-010-0556-7